MarketPeel
Insider Trading Intelligence
MT

Melissa Tosca

KPRX
CFO · KIORA PHARMACEUTICALS INC · CIK 0001947184
FILING MIX · LIFETIME88%/12%
BUYS
14
SELLS
2
TOTAL VALUE
$11.2K
COMPANIES
1
ACTIVE SINCE
Oct 2022
HOLDINGS NOW
26,064
AVG SELL PX
$2.30
TRADE KIND
SHOWING 16 / 16
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 1 pending
Forward-return performance of every backtestable P/S trade by Melissa Tosca, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+50.00%+0.99%+1.87%-0.88%-0.88%
14d2+50.00%-0.34%+1.63%-1.97%-1.97%
30d2+50.00%-2.53%+3.57%-6.11%-6.11%
60d2+0.00%-20.62%+3.99%-24.60%-24.60%
90d2+50.00%-7.84%+6.72%-14.57%-14.57%
180d2+50.00%-9.19%+12.29%-21.48%-21.48%
1y2+0.00%-31.02%+15.56%-46.58%-46.58%
2y2(1 pending)+0.00%-51.81%+36.66%-88.47%-88.47%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
KPRX · 26,064 shares · as of Jul 1, 2026
015,00030,00045,00060,0002023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 14 buys / 2 sellsCOVERAGE · 16 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
KPRX
KIORA PHARMACEUTICALS INC
SALE
CFO
911$2.66$2.4K26,064Jul 1, 2026Jul 2, 2026View →
KPRX
KIORA PHARMACEUTICALS INC
SALE
CFO
929$1.95$1.8K26,975Apr 1, 2026Apr 2, 2026View →
KPRX
KIORA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
6,53327,904Mar 6, 2026Mar 10, 2026View →
KPRX
KIORA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
13,06713,067Mar 6, 2026Mar 10, 2026View →
KPRX
KIORA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
15,54315,543Apr 1, 2025Apr 2, 2025View →
KPRX
KIORA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
7,77221,371Apr 1, 2025Apr 2, 2025View →
KPRX
KIORA PHARMACEUTICALS INC
PURCHASE
CFO
2,000$3.21$6.4K13,599Aug 14, 2024Aug 15, 2024View →
KPRX
KIORA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
15,23915,239Jul 1, 2024Jul 3, 2024View →
KPRX
KIORA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
7,62011,599Jul 1, 2024Jul 3, 2024View →
KPRX
KIORA PHARMACEUTICALS INC
PURCHASE
EVP Finance
100$5.25$5253,979Jun 14, 2024Jun 14, 2024View →
KPRX
KIORA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
30,00034,900Sep 29, 2023Oct 3, 2023View →
KPRX
KIORA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
60,00060,000Sep 29, 2023Oct 3, 2023View →
KPRX
KIORA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
1,6001,600Mar 3, 2023Mar 7, 2023View →
KPRX
KIORA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
2,4007,400Mar 3, 2023Mar 7, 2023View →
KPRX
KIORA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
2,5002,500Oct 21, 2022Oct 25, 2022View →
KPRX
KIORA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
5,0005,000Oct 21, 2022Oct 25, 2022View →
Other insiders · KPRX
Loading peer insiders…
About this filer
CIK 0001947184
ROLE
CFO
PRIMARY
KPRX
COMPANIES
1
ACTIVE SINCE
Oct 2022
MARKETPEEL · /INSIDER/0001947184DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback